特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

キャリアスクリーニングの世界市場

Carrier Screening

発行 Global Industry Analysts, Inc. 商品コード 938813
出版日 ページ情報 英文 288 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

キャリアスクリーニングの世界市場 Carrier Screening
出版日: 2020年07月01日 ページ情報: 英文 288 Pages
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
概要

世界のキャリアスクリーニングの市場は、新型コロナウイルス感染症 (COVID-19) の世界的流行とそれに伴う経済不況の中、予測期間中8.4%のCAGRで推移すると予測されています。タイプ別では、分子スクリーニングテスト部門が同期間中8.9%を超えるCAGRで成長する見通しです。歴史上例のないCOVID-19の大流行は、あらゆる産業にかつて経験したことのない様々な影響を及ぼしています。分子スクリーニングテスト部門も、ポストCOVID-19時代に向けたニューノーマル(新常態)を構築することとなるでしょう。新たなシナリオで見ると、地域別では、米国が7.1%のCAGRで推移する見通しです。欧州の中で大流行の影響を大きく受けたドイツの市場規模は、今後7-8年で7410万米ドルを超える規模の拡大を示す見通しです。また他の欧州地域では、6480万米ドルを超える規模の需要が見込まれています。一方、日本の分子スクリーニングテスト市場は予測期間末までに1億4000万米ドルの市場規模に成長する見通しです。また、今回の大流行の発端となり深刻な政治的および経済的課題に直面する中国は、さまざまな障壁にもかかわらず、今後数年間で12.1%の成長を示す見通しです。

調査対象企業の例

  • 23andMe, Inc.
  • Abbott Laboratories
  • AutoGenomics, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Luminex Corporation
  • Myriad Genetics, Inc.
  • Sequenom, Inc.
  • Thermo Fisher Scientific, Inc.

当レポートでは、世界のキャリアスクリーニングの市場を調査し、市場および技術の概要、市場成長への各種影響因子の分析、市場規模の推移と予測、各種区分・地域・主要国別の詳細分析、競合環境、主要企業プロファイルなどをまとめています。

I イントロダクション・調査手法・調査範囲

II エグゼクティブサマリー

第1章 市場概要

  • 世界の企業シェア
  • 企業シェアシナリオ
  • Covid-19の影響・景気後退の見通し

第2章 主要企業

第3章 市場動向・成長推進因子

第4章 世界市場の展望

III 市場分析

  • 市場分析:地域・主要国別

IV 競合

  • 企業プロファイル
目次
Product Code: MCP10911

Global Carrier Screening Market to Reach $4.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Carrier Screening estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$4.6 Billion by 2027, growing at aCAGR of 8.4% over the period 2020-2027. Molecular Screening Test, one of the segments analyzed in the report, is projected to record 8.9% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biochemical Screening Test segment is readjusted to a revised 7.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $710.2 Million, While China is Forecast to Grow at 11.3% CAGR

The Carrier Screening market in the U.S. is estimated at US$710.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$958.5 Million by the year 2027 trailing a CAGR of 11.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.6% and 7.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.We bring years of research experience to this 7th edition of our report. The 288-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • 23andMe, Inc.
  • Abbott Laboratories
  • AutoGenomics, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Luminex Corporation
  • Myriad Genetics, Inc.
  • Sequenom, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Carrier Screening Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Carrier Screening Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Carrier Screening Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Carrier Screening Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Molecular Screening Test (Test Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Molecular Screening Test (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Molecular Screening Test (Test Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Biochemical Screening Test (Test Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Biochemical Screening Test (Test Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Biochemical Screening Test (Test Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Cystic Fibrosis (Disease Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Cystic Fibrosis (Disease Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Cystic Fibrosis (Disease Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Tay-Sachs (Disease Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Tay-Sachs (Disease Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: Tay-Sachs (Disease Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Gaucher Disease (Disease Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 17: Gaucher Disease (Disease Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 18: Gaucher Disease (Disease Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Sickle Cell Disease (Disease Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
  • TABLE 20: Sickle Cell Disease (Disease Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 21: Sickle Cell Disease (Disease Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 22: Spinal Muscular Atrophy (Disease Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
  • TABLE 23: Spinal Muscular Atrophy (Disease Type) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019
  • TABLE 24: Spinal Muscular Atrophy (Disease Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Genetic Disorders (Disease Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 26: Genetic Disorders (Disease Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 27: Genetic Disorders (Disease Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 28: Other Disease Types (Disease Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 29: Other Disease Types (Disease Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 30: Other Disease Types (Disease Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Carrier Screening Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 31: United States Carrier Screening Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 32: Carrier Screening Market in the United States by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 33: United States Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 34: United States Carrier Screening Market Estimates and Projections in US$ Million by Disease Type: 2020 to 2027
    • TABLE 35: Carrier Screening Market in the United States by Disease Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 36: United States Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 37: Canadian Carrier Screening Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 38: Canadian Carrier Screening Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 39: Carrier Screening Market in Canada: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
    • TABLE 40: Canadian Carrier Screening Market Estimates and Forecasts in US$ Million by Disease Type: 2020 to 2027
    • TABLE 41: Canadian Carrier Screening Historic Market Review by Disease Type in US$ Million: 2012-2019
    • TABLE 42: Carrier Screening Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2012, 2020, and 2027
  • JAPAN
    • TABLE 43: Japanese Market for Carrier Screening: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 44: Carrier Screening Market in Japan: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 45: Japanese Carrier Screening Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 46: Japanese Market for Carrier Screening: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 47: Carrier Screening Market in Japan: Historic Sales Analysis in US$ Million by Disease Type for the Period 2012-2019
    • TABLE 48: Japanese Carrier Screening Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 49: Chinese Carrier Screening Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 50: Carrier Screening Historic Market Analysis in China in US$ Million by Test Type: 2012-2019
    • TABLE 51: Chinese Carrier Screening Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 52: Chinese Carrier Screening Market Growth Prospects in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 53: Carrier Screening Historic Market Analysis in China in US$ Million by Disease Type: 2012-2019
    • TABLE 54: Chinese Carrier Screening Market by Disease Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • EUROPE
    • Market Facts & Figures
    • European Carrier Screening Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 55: European Carrier Screening Market Demand Scenario in US$ Million by Region/Country: 2020-2027
    • TABLE 56: Carrier Screening Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 57: European Carrier Screening Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 58: European Carrier Screening Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 59: Carrier Screening Market in Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 60: European Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 61: European Carrier Screening Market Estimates and Forecasts in US$ Million by Disease Type: 2020-2027
    • TABLE 62: Carrier Screening Market in Europe in US$ Million by Disease Type: A Historic Review for the Period 2012-2019
    • TABLE 63: European Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 64: Carrier Screening Market in France by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 65: French Carrier Screening Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 66: French Carrier Screening Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 67: Carrier Screening Market in France by Disease Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 68: French Carrier Screening Historic Market Scenario in US$ Million by Disease Type: 2012-2019
    • TABLE 69: French Carrier Screening Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
  • GERMANY
    • TABLE 70: Carrier Screening Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 71: German Carrier Screening Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 72: German Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 73: Carrier Screening Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 74: German Carrier Screening Historic Market Analysis in US$ Million by Disease Type: 2012-2019
    • TABLE 75: German Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 76: Italian Carrier Screening Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 77: Carrier Screening Historic Market Analysis in Italy in US$ Million by Test Type: 2012-2019
    • TABLE 78: Italian Carrier Screening Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 79: Italian Carrier Screening Market Growth Prospects in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 80: Carrier Screening Historic Market Analysis in Italy in US$ Million by Disease Type: 2012-2019
    • TABLE 81: Italian Carrier Screening Market by Disease Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED KINGDOM
    • TABLE 82: United Kingdom Market for Carrier Screening: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 83: Carrier Screening Market in the United Kingdom: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 84: United Kingdom Carrier Screening Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 85: United Kingdom Market for Carrier Screening: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 86: Carrier Screening Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disease Type for the Period 2012-2019
    • TABLE 87: United Kingdom Carrier Screening Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
  • SPAIN
    • TABLE 88: Spanish Carrier Screening Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 89: Spanish Carrier Screening Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 90: Carrier Screening Market in Spain: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
    • TABLE 91: Spanish Carrier Screening Market Estimates and Forecasts in US$ Million by Disease Type: 2020 to 2027
    • TABLE 92: Spanish Carrier Screening Historic Market Review by Disease Type in US$ Million: 2012-2019
    • TABLE 93: Carrier Screening Market in Spain: Percentage Share Breakdown of Sales by Disease Type for 2012, 2020, and 2027
  • RUSSIA
    • TABLE 94: Russian Carrier Screening Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 95: Carrier Screening Market in Russia by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 96: Russian Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 97: Russian Carrier Screening Market Estimates and Projections in US$ Million by Disease Type: 2020 to 2027
    • TABLE 98: Carrier Screening Market in Russia by Disease Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 99: Russian Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 100: Rest of Europe Carrier Screening Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 101: Carrier Screening Market in Rest of Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 102: Rest of Europe Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 103: Rest of Europe Carrier Screening Market Estimates and Forecasts in US$ Million by Disease Type: 2020-2027
    • TABLE 104: Carrier Screening Market in Rest of Europe in US$ Million by Disease Type: A Historic Review for the Period 2012-2019
    • TABLE 105: Rest of Europe Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 106: Asia-Pacific Carrier Screening Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 107: Carrier Screening Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 108: Asia-Pacific Carrier Screening Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 109: Carrier Screening Market in Asia-Pacific by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 110: Asia-Pacific Carrier Screening Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 111: Asia-Pacific Carrier Screening Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 112: Carrier Screening Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 113: Asia-Pacific Carrier Screening Historic Market Scenario in US$ Million by Disease Type: 2012-2019
    • TABLE 114: Asia-Pacific Carrier Screening Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
  • AUSTRALIA
    • TABLE 115: Carrier Screening Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 116: Australian Carrier Screening Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 117: Australian Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 118: Carrier Screening Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 119: Australian Carrier Screening Historic Market Analysis in US$ Million by Disease Type: 2012-2019
    • TABLE 120: Australian Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • INDIA
    • TABLE 121: Indian Carrier Screening Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 122: Indian Carrier Screening Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 123: Carrier Screening Market in India: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
    • TABLE 124: Indian Carrier Screening Market Estimates and Forecasts in US$ Million by Disease Type: 2020 to 2027
    • TABLE 125: Indian Carrier Screening Historic Market Review by Disease Type in US$ Million: 2012-2019
    • TABLE 126: Carrier Screening Market in India: Percentage Share Breakdown of Sales by Disease Type for 2012, 2020, and 2027
  • SOUTH KOREA
    • TABLE 127: Carrier Screening Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 128: South Korean Carrier Screening Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 129: Carrier Screening Market Share Distribution in South Korea by Test Type: 2012 VS 2020 VS 2027
    • TABLE 130: Carrier Screening Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 131: South Korean Carrier Screening Historic Market Analysis in US$ Million by Disease Type: 2012-2019
    • TABLE 132: Carrier Screening Market Share Distribution in South Korea by Disease Type: 2012 VS 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 133: Rest of Asia-Pacific Market for Carrier Screening: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 134: Carrier Screening Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 135: Rest of Asia-Pacific Carrier Screening Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 136: Rest of Asia-Pacific Market for Carrier Screening: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 137: Carrier Screening Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Disease Type for the Period 2012-2019
    • TABLE 138: Rest of Asia-Pacific Carrier Screening Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
  • LATIN AMERICA
    • TABLE 139: Latin American Carrier Screening Market Trends by Region/Country in US$ Million: 2020-2027
    • TABLE 140: Carrier Screening Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
    • TABLE 141: Latin American Carrier Screening Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    • TABLE 142: Latin American Carrier Screening Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 143: Carrier Screening Historic Market Analysis in Latin America in US$ Million by Test Type: 2012-2019
    • TABLE 144: Latin American Carrier Screening Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 145: Latin American Carrier Screening Market Growth Prospects in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 146: Carrier Screening Historic Market Analysis in Latin America in US$ Million by Disease Type: 2012-2019
    • TABLE 147: Latin American Carrier Screening Market by Disease Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • ARGENTINA
    • TABLE 148: Argentinean Carrier Screening Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 149: Carrier Screening Market in Argentina in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 150: Argentinean Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 151: Argentinean Carrier Screening Market Estimates and Forecasts in US$ Million by Disease Type: 2020-2027
    • TABLE 152: Carrier Screening Market in Argentina in US$ Million by Disease Type: A Historic Review for the Period 2012-2019
    • TABLE 153: Argentinean Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • BRAZIL
    • TABLE 154: Carrier Screening Market in Brazil by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 155: Brazilian Carrier Screening Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 156: Brazilian Carrier Screening Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 157: Carrier Screening Market in Brazil by Disease Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 158: Brazilian Carrier Screening Historic Market Scenario in US$ Million by Disease Type: 2012-2019
    • TABLE 159: Brazilian Carrier Screening Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
  • MEXICO
    • TABLE 160: Carrier Screening Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 161: Mexican Carrier Screening Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 162: Mexican Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 163: Carrier Screening Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 164: Mexican Carrier Screening Historic Market Analysis in US$ Million by Disease Type: 2012-2019
    • TABLE 165: Mexican Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 166: Rest of Latin America Carrier Screening Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 167: Carrier Screening Market in Rest of Latin America by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 168: Rest of Latin America Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 169: Rest of Latin America Carrier Screening Market Estimates and Projections in US$ Million by Disease Type: 2020 to 2027
    • TABLE 170: Carrier Screening Market in Rest of Latin America by Disease Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 171: Rest of Latin America Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • MIDDLE EAST
    • TABLE 172: The Middle East Carrier Screening Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 173: Carrier Screening Market in the Middle East by Region/Country in US$ Million: 2012-2019
    • TABLE 174: The Middle East Carrier Screening Market Share Breakdown by Region/Country: 2012, 2020, and 2027
    • TABLE 175: The Middle East Carrier Screening Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 176: The Middle East Carrier Screening Historic Market by Test Type in US$ Million: 2012-2019
    • TABLE 177: Carrier Screening Market in the Middle East: Percentage Share Breakdown of Sales by Test Type for 2012,2020, and 2027
    • TABLE 178: The Middle East Carrier Screening Market Estimates and Forecasts in US$ Million by Disease Type: 2020 to 2027
    • TABLE 179: The Middle East Carrier Screening Historic Market by Disease Type in US$ Million: 2012-2019
    • TABLE 180: Carrier Screening Market in the Middle East: Percentage Share Breakdown of Sales by Disease Type for 2012,2020, and 2027
  • IRAN
    • TABLE 181: Iranian Market for Carrier Screening: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 182: Carrier Screening Market in Iran: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 183: Iranian Carrier Screening Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 184: Iranian Market for Carrier Screening: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 185: Carrier Screening Market in Iran: Historic Sales Analysis in US$ Million by Disease Type for the Period 2012-2019
    • TABLE 186: Iranian Carrier Screening Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
  • ISRAEL
    • TABLE 187: Israeli Carrier Screening Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 188: Carrier Screening Market in Israel in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 189: Israeli Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 190: Israeli Carrier Screening Market Estimates and Forecasts in US$ Million by Disease Type: 2020-2027
    • TABLE 191: Carrier Screening Market in Israel in US$ Million by Disease Type: A Historic Review for the Period 2012-2019
    • TABLE 192: Israeli Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • SAUDI ARABIA
    • TABLE 193: Saudi Arabian Carrier Screening Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 194: Carrier Screening Historic Market Analysis in Saudi Arabia in US$ Million by Test Type: 2012-2019
    • TABLE 195: Saudi Arabian Carrier Screening Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 196: Saudi Arabian Carrier Screening Market Growth Prospects in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 197: Carrier Screening Historic Market Analysis in Saudi Arabia in US$ Million by Disease Type: 2012-2019
    • TABLE 198: Saudi Arabian Carrier Screening Market by Disease Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED ARAB EMIRATES
    • TABLE 199: Carrier Screening Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 200: United Arab Emirates Carrier Screening Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 201: Carrier Screening Market Share Distribution in United Arab Emirates by Test Type: 2012 VS 2020 VS 2027
    • TABLE 202: Carrier Screening Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 203: United Arab Emirates Carrier Screening Historic Market Analysis in US$ Million by Disease Type: 2012-2019
    • TABLE 204: Carrier Screening Market Share Distribution in United Arab Emirates by Disease Type: 2012 VS 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 205: Carrier Screening Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 206: Rest of Middle East Carrier Screening Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 207: Rest of Middle East Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 208: Carrier Screening Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2020-2027
    • TABLE 209: Rest of Middle East Carrier Screening Historic Market Analysis in US$ Million by Disease Type: 2012-2019
    • TABLE 210: Rest of Middle East Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
  • AFRICA
    • TABLE 211: African Carrier Screening Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 212: Carrier Screening Market in Africa by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 213: African Carrier Screening Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 214: African Carrier Screening Market Estimates and Projections in US$ Million by Disease Type: 2020 to 2027
    • TABLE 215: Carrier Screening Market in Africa by Disease Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 216: African Carrier Screening Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 42